30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Cassava Sciences Inc (SAVA)

Track

The most recent insider trading activity occurred on November 24, 2025. Prior to this, significant buying activity was observed in September and November 2025, primarily by Richard Barry, President & CEO. Earlier transactions in November 2024 involved sales by officers, including Eric Schoen. The last reported buy transaction predates the last reported sell transaction.
Stock chart
Ticker: SAVA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Anderson Robert Eugene Jr
1 purchase — total 24,940 USD
Buy 24 Nov 2025
Value US$4,449,056.53 | Price 87.27 | Shares 80,670
Buy 20 Nov 2025
Value US$1,799,401.43 | Price 14.38 | Shares 28,534
Buy 19 Nov 2025
Value US$201,808.75 | Price 2.75 | Shares 73,385
Buy 30 Sep 2025
Value US$39,939.75 | Price 2.91 | Shares 13,725
Buy 22 Sep 2025
Value US$16,352.16 | Price 2.28 | Shares 7,172
Buy 19 Sep 2025
Value US$107,419.32 | Price 2.29 | Shares 46,908
Buy 19 Sep 2025
Value US$900.00 | Price 2.25 | Shares 400
Buy 18 Sep 2025
Value US$414,921.92 | Price 2.24 | Shares 185,233
Buy 18 Sep 2025
Value US$11,502.00 | Price 2.13 | Shares 5,400
Sale 29 Nov 2024
Value US$230,828.00 | Price 3.86 | Shares 59,800
Sale 29 Nov 2024
Value US$7,640.00 | Price 3.82 | Shares 2,000
Proposed sale 29 Nov 2024
Value US$230,965.85 | Price 3.86 | Shares 59,800
Sale 29 Nov 2024
Value US$15,480.00 | Price 3.87 | Shares 4,000
Proposed sale 29 Nov 2024
Value US$7,640.20 | Price 3.82 | Shares 2,000
Buy 23 Aug 2023
Value US$523,500.00 | Price 17.45 | Shares 30,000
Buy 22 Aug 2023
Value US$275,907.15 | Price 16.65 | Shares 16,571
Buy 21 Aug 2023
Value US$32,020.80 | Price 16.80 | Shares 1,906
Buy 7 Mar 2023
Value US$1,990,629.76 | Price 25.76 | Shares 77,276
Buy 6 Mar 2023
Value US$302,193.45 | Price 26.13 | Shares 11,565
Buy 23 Aug 2022
Value US$860,222.61 | Price 23.79 | Shares 36,159
Buy 23 Aug 2022
Value US$61,100.00 | Price 24.44 | Shares 2,500
Buy 12 Aug 2022
Value US$2,069,000.00 | Price 20.69 | Shares 100,000
Buy 12 Aug 2022
Value US$49,875.00 | Price 19.95 | Shares 2,500
Buy 24 Sep 2020
Value US$95,900.00 | Price 9.59 | Shares 10,000
Buy 18 Sep 2020
Value US$323,626.52 | Price 8.92 | Shares 36,281
Buy 17 Sep 2020
Value US$14,080.00 | Price 7.04 | Shares 2,000
Buy 17 Sep 2020
Value US$70,300.00 | Price 7.03 | Shares 10,000
Buy 17 Sep 2020
Value US$1,491,758.62 | Price 6.98 | Shares 213,719
Buy 31 Dec 2019
Value US$553,000.00 | Price 5.53 | Shares 100,000
Buy 26 Dec 2019
Value US$41,500.00 | Price 4.15 | Shares 10,000
Buy 20 Dec 2019
Value US$932,333.60 | Price 2.20 | Shares 423,788
Buy 19 Dec 2019
Value US$141,754.32 | Price 1.86 | Shares 76,212
Buy 19 Dec 2019
Value US$9,964.00 | Price 1.88 | Shares 5,300
Buy 18 Dec 2019
Value US$4,288.35 | Price 1.65 | Shares 2,599
Buy 14 May 2019
Value US$10,600.00 | Price 1.06 | Shares 10,000
Sale 3 Oct 2018
Value US$0.00 | Price 0.00 | Shares 0
Sale 3 Oct 2018
Value US$0.00 | Price 0.00 | Shares 0
Sale 3 Oct 2018
Value US$671,738.40 | Price 1.31 | Shares 512,660
Buy 27 Sep 2018
Value US$39,707.85 | Price 1.05 | Shares 37,817
Buy 26 Sep 2018
Value US$32,541.60 | Price 1.05 | Shares 30,992
Buy 25 Sep 2018
Value US$21,420.00 | Price 1.00 | Shares 21,420
Buy 24 Sep 2018
Value US$9,380.16 | Price 0.96 | Shares 9,771
Sale 20 Aug 2018
Value US$0.00 | Price 0.00 | Shares 0
Sale 20 Aug 2018
Value US$0.00 | Price 0.00 | Shares 0
Sale 20 Aug 2018
Value US$7,254.40 | Price 0.91 | Shares 8,000
Sale 17 Aug 2018
Value US$0.00 | Price 0.00 | Shares 0
Sale 17 Aug 2018
Value US$0.00 | Price 0.00 | Shares 0
Sale 17 Aug 2018
Value US$45,681.60 | Price 0.95 | Shares 48,000
Sale 16 Aug 2018
Value US$0.00 | Price 0.00 | Shares 0
Sale 16 Aug 2018
Value US$0.00 | Price 0.00 | Shares 0
Sale 16 Aug 2018
Value US$1,222,200.00 | Price 1.02 | Shares 1,200,000
Buy 6 Nov 2013
Value US$119,710.88 | Price 3.76 | Shares 31,838
Buy 4 Nov 2013
Value US$67,017.78 | Price 3.69 | Shares 18,162
Sale 18 Oct 2011
Value US$111,007.50 | Price 4.44 | Shares 25,000
Sale 4 Oct 2011
Value US$237,500.00 | Price 4.75 | Shares 50,000
Sale 4 Oct 2011
Value US$1,193,162.50 | Price 4.50 | Shares 265,000
Sale 4 Oct 2011
Value US$32,118.10 | Price 4.59 | Shares 7,000
Sale 3 Oct 2011
Value US$323,409.00 | Price 4.83 | Shares 67,000
Sale 3 Oct 2011
Value US$39,122.40 | Price 4.89 | Shares 8,000
Sale 30 Sep 2011
Value US$49,060.00 | Price 4.91 | Shares 10,000
Sale 15 Sep 2011
Value US$122,125.00 | Price 4.89 | Shares 25,000
Sale 8 Aug 2011
Value US$186,600.26 | Price 4.20 | Shares 44,417
Buy 8 Aug 2011
Value US$21,095.00 | Price 4.22 | Shares 5,000
Planned sale 4 Oct 2010
Value US$91,950.00 | Price 6.13 | Shares 15,000
Planned sale 7 Sep 2010
Value US$91,078.40 | Price 5.60 | Shares 16,264
Planned sale 2 Sep 2010
Value US$65,139.39 | Price 5.87 | Shares 11,097
Planned sale 9 Aug 2010
Value US$37,585.55 | Price 5.81 | Shares 6,468
Planned sale 6 Aug 2010
Value US$52,541.37 | Price 5.53 | Shares 9,496
Planned sale 4 Aug 2010
Value US$37,129.06 | Price 5.64 | Shares 6,582
Planned sale 3 Aug 2010
Value US$37,108.38 | Price 5.75 | Shares 6,457
Planned sale 16 Jul 2010
Value US$8,310.00 | Price 5.54 | Shares 1,500
Planned sale 7 Jul 2010
Value US$37,964.20 | Price 5.37 | Shares 7,071
Planned sale 2 Jul 2010
Value US$59,976.73 | Price 5.42 | Shares 11,065
Planned sale 16 Jun 2010
Value US$8,175.00 | Price 5.45 | Shares 1,500
Planned sale 3 Jun 2010
Value US$45,564.38 | Price 5.53 | Shares 8,238
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-25 2025-11-24 B Purchase
0.6
Anderson Robert Eugene Jr
Non-Executive Director
80,670 -31.7%
87.27
US$4,449,057 		80,670 -31.7% 87.27 US$4,449,057
2025-11-24 2025-11-20 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
28,534 -38.0%
14.38
US$1,799,401 		28,534 -38.0% 14.38 US$1,799,401
2025-11-20 2025-11-19 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
75,994 -0.7%
496.37
US$229,588 		75,994 -0.7% 496.37 US$229,588
2025-10-02 2025-09-30 B Purchase
1.5
Cook Robert Christopher

Chief Operating & Legal Office

Officer
13,725 +inf%
2.91
US$39,940 		13,725 +inf% 2.91 US$39,940
2025-09-23 2025-09-22 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
7,172 +1.0%
2.28
US$16,352 		7,172 +1.0% 2.28 US$16,352
2025-09-22 2025-09-19 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
46,908 +7.1%
2.29
US$107,419 		46,908 +7.1% 2.29 US$107,419
2025-09-22 2025-09-19 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
400 +0.1%
2.25
US$900 		400 +0.1% 2.25 US$900
2025-09-22 2025-09-18 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
185,233 +39.0%
2.24
US$414,922 		185,233 +39.0% 2.24 US$414,922
2025-09-22 2025-09-18 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
5,400 +1.2%
2.13
US$11,502 		5,400 +1.2% 2.13 US$11,502
2024-12-03 2024-11-29 S Sale
3.0
Schoen Eric

Chief Financial Officer

Officer
59,800 -83.9%
3.86
US$230,828 		59,800 -83.9% 3.86 US$230,828
2024-12-03 2024-11-29 S Sale
3.0
Schoen Eric

Chief Financial Officer

Officer
2,000 -100.0%
3.82
US$7,640 		2,000 -100.0% 3.82 US$7,640
2024-12-03 2024-11-29 S Sale
2.3
Kupiec James William

Chief Medical Officer

Officer
4,000 -100.0%
3.87
US$15,480 		4,000 -100.0% 3.87 US$15,480
2024-12-02 2024-11-29 PrS Proposed sale
3.0
Schoen, Eric J. (SAVA)

Officer

Officer
2,000
3.82
US$7,640 		2,000 3.82 US$7,640
2024-11-29 2024-11-29 PrS Proposed sale
3.0
Schoen Eric

Officer

Officer
59,800
3.86
US$230,966 		59,800 3.86 US$230,966
2023-08-24 2023-08-23 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
30,000 +3.5%
17.45
US$523,500 		30,000 +3.5% 17.45 US$523,500
2023-08-23 2023-08-22 B Purchase
3.2
Barry Richard
Non-Executive Director
16,571 +6.0%
16.65
US$275,907 		16,571 +6.0% 16.65 US$275,907
2023-08-23 2023-08-21 B Purchase
3.2
Barry Richard
Non-Executive Director
1,906 +0.7%
16.80
US$32,021 		1,906 +0.7% 16.80 US$32,021
2023-03-08 2023-03-07 B Purchase
3.2
Barry Richard
Non-Executive Director
77,276 +39.1%
25.76
US$1,990,630 		77,276 +39.1% 25.76 US$1,990,630
2023-03-08 2023-03-06 B Purchase
3.2
Barry Richard
Non-Executive Director
11,565 +6.2%
26.13
US$302,193 		11,565 +6.2% 26.13 US$302,193
2022-08-25 2022-08-23 B Purchase
3.2
Barry Richard
Non-Executive Director
36,159 +24.1%
23.79
US$860,223 		36,159 +24.1% 23.79 US$860,223
2022-08-24 2022-08-23 B Purchase
2.3
Kupiec James William

Chief Clinical Dev. Officer

Officer
2,500 +inf%
24.44
US$61,100 		2,500 +inf% 24.44 US$61,100
2022-08-16 2022-08-12 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
100,000 +10.8%
20.69
US$2,069,000 		100,000 +10.8% 20.69 US$2,069,000
2022-08-16 2022-08-12 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
2,500 +14.5%
19.95
US$49,875 		2,500 +14.5% 19.95 US$49,875
2020-09-24 2020-09-24 B Purchase
1.6
BARBIER REMI

President and CEO

Executive Director
10,000 +0.9%
9.59
US$95,900 		10,000 +0.9% 9.59 US$95,900
2020-09-21 2020-09-18 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
36,281 +4.1%
8.92
US$323,627 		36,281 +4.1% 8.92 US$323,627
2020-09-17 2020-09-17 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
2,000 +7.9%
7.04
US$14,080 		2,000 +7.9% 7.04 US$14,080
2020-09-17 2020-09-17 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
213,719 +32.3%
6.98
US$1,491,759 		213,719 +32.3% 6.98 US$1,491,759
2020-09-17 2020-09-17 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
10,000 +65.4%
7.03
US$70,300 		10,000 +65.4% 7.03 US$70,300
2019-12-31 2019-12-31 B Purchase BARBIER REMI

President and CEO

Executive Director
100,000 +10.3%
5.53
US$553,000 		100,000 +10.3% 5.53 US$553,000
2019-12-26 2019-12-26 B Purchase BARBIER REMI

President and CEO

Executive Director
10,000 +1.0%
4.15
US$41,500 		10,000 +1.0% 4.15 US$41,500
2019-12-20 2019-12-20 B Purchase ROBERTSON SANFORD Non-Executive Director
423,788 +177.4%
2.20
US$932,334 		423,788 +177.4% 2.20 US$932,334
2019-12-19 2019-12-19 B Purchase ROBERTSON SANFORD Non-Executive Director
76,212 +46.9%
1.86
US$141,754 		76,212 +46.9% 1.86 US$141,754
2019-12-19 2019-12-19 B Purchase Schoen Eric

Chief Financial Officer

Officer
5,300 +53.0%
1.88
US$9,964 		5,300 +53.0% 1.88 US$9,964
2019-12-20 2019-12-18 B Purchase BARBIER REMI

President and CEO

Executive Director
2,599 +inf%
1.65
US$4,288 		2,599 +inf% 1.65 US$4,288
2019-05-15 2019-05-14 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
10,000 +inf%
1.06
US$10,600 		10,000 +inf% 1.06 US$10,600
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
512,660 -23.7%
1.31
US$671,738 		512,660 -23.7% 1.31 US$671,738
2018-09-27 2018-09-27 B Purchase ROBERTSON SANFORD Non-Executive Director
37,817 +30.3%
1.05
US$39,708 		37,817 +30.3% 1.05 US$39,708
2018-09-26 2018-09-26 B Purchase ROBERTSON SANFORD Non-Executive Director
30,992 +33.0%
1.05
US$32,542 		30,992 +33.0% 1.05 US$32,542
2018-09-26 2018-09-25 B Purchase ROBERTSON SANFORD Non-Executive Director
21,420 +29.6%
1.00
US$21,420 		21,420 +29.6% 1.00 US$21,420
2018-09-26 2018-09-24 B Purchase ROBERTSON SANFORD Non-Executive Director
9,771 +15.6%
0.96
US$9,380 		9,771 +15.6% 0.96 US$9,380
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
8,000 -0.4%
0.91
US$7,254 		8,000 -0.4% 0.91 US$7,254
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
48,000 -2.2%
0.95
US$45,682 		48,000 -2.2% 0.95 US$45,682
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
1,200,000 -35.1%
1.02
US$1,222,200 		1,200,000 -35.1% 1.02 US$1,222,200
2013-11-07 2013-11-06 B Purchase ROBERTSON SANFORD Non-Executive Director
31,838 +9.4%
3.76
US$119,711 		31,838 +9.4% 3.76 US$119,711
2013-11-07 2013-11-04 B Purchase ROBERTSON SANFORD Non-Executive Director
18,162 +5.7%
3.69
US$67,018 		18,162 +5.7% 3.69 US$67,018
2011-10-24 2011-10-18 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
25,000 -8.8%
4.44
US$111,008 		25,000 -8.8% 4.44 US$111,008
2011-10-05 2011-10-04 S Sale Sabretooth Master Fund, L.P. Large shareholder
50,000 -1.2%
4.75
US$237,500 		50,000 -1.2% 4.75 US$237,500
2011-10-05 2011-10-04 S Sale Sabretooth Master Fund, L.P. Large shareholder
265,000 -5.8%
4.50
US$1,193,162 		265,000 -5.8% 4.50 US$1,193,162
2011-10-04 2011-10-04 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
7,000 -2.4%
4.59
US$32,118 		7,000 -2.4% 4.59 US$32,118
2011-10-05 2011-10-03 S Sale Sabretooth Master Fund, L.P. Large shareholder
67,000 -1.4%
4.83
US$323,409 		67,000 -1.4% 4.83 US$323,409
2011-10-04 2011-10-03 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
8,000 -2.7%
4.89
US$39,122 		8,000 -2.7% 4.89 US$39,122
2011-10-04 2011-09-30 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
10,000 -3.2%
4.91
US$49,060 		10,000 -3.2% 4.91 US$49,060
2011-09-21 2011-09-15 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
25,000 -7.5%
4.89
US$122,125 		25,000 -7.5% 4.89 US$122,125
2011-08-10 2011-08-08 S Sale Sabretooth Master Fund, L.P. Large shareholder
44,417 -0.9%
4.20
US$186,600 		44,417 -0.9% 4.20 US$186,600
2011-08-08 2011-08-08 B Purchase BARBIER REMI

CEO, Chairman of the Board

Executive Director Large shareholder
5,000 +0.1%
4.22
US$21,095 		5,000 +0.1% 4.22 US$21,095
2010-10-04 2010-10-04 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
15,000 -0.3%
6.13
US$91,950 		15,000 -0.3% 6.13 US$91,950
2010-09-08 2010-09-07 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
16,264 -0.3%
5.60
US$91,078 		16,264 -0.3% 5.60 US$91,078
2010-09-02 2010-09-02 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
11,097 -0.2%
5.87
US$65,139 		11,097 -0.2% 5.87 US$65,139
2010-08-10 2010-08-09 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
6,468 -0.1%
5.81
US$37,586 		6,468 -0.1% 5.81 US$37,586
2010-08-10 2010-08-06 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
9,496 -0.2%
5.53
US$52,541 		9,496 -0.2% 5.53 US$52,541
2010-08-04 2010-08-04 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
6,582 -0.1%
5.64
US$37,129 		6,582 -0.1% 5.64 US$37,129
2010-08-04 2010-08-03 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
6,457 -0.1%
5.75
US$37,108 		6,457 -0.1% 5.75 US$37,108
2010-07-20 2010-07-16 PlS Planned sale SCHOENHARD GRANT

Chief Scientific Officer

Officer
1,500 -3.0%
5.54
US$8,310 		1,500 -3.0% 5.54 US$8,310
2010-07-08 2010-07-07 PlS Planned sale BARBIER REMI

CEO and Chairman of the Board

Executive Director Large shareholder
7,071 -0.1%
5.37
US$37,964 		7,071 -0.1% 5.37 US$37,964
2010-07-02 2010-07-02 PlS Planned sale BARBIER REMI

CEO and Chairman of the Board

Executive Director Large shareholder
11,065 -0.2%
5.42
US$59,977 		11,065 -0.2% 5.42 US$59,977
2010-06-17 2010-06-16 PlS Planned sale SCHOENHARD GRANT

Chief Scientific Officer

Officer
1,500 -3.0%
5.45
US$8,175 		1,500 -3.0% 5.45 US$8,175
2010-06-03 2010-06-03 PlS Planned sale BARBIER REMI

CEO and Chairman of Board

Executive Director Large shareholder
8,238 -0.1%
5.53
US$45,564 		8,238 -0.1% 5.53 US$45,564
Explore more

More insider trading research around Cassava Sciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America